OSL oncosil medical ltd
Add to My Watchlist 0.00% ! $1.16

Ann: Positive PanCO trial update on resected cohort, page-8

  1. vrs37
    697 Posts.
    lightbulb Created with Sketch. 262
    clock Created with Sketch.
    20/10/20
    13:25
    Post #: 48234603
    Yep brilliant explanation thanks
    and chemo also destroys the cancer cells that spread throughout the body early in this cancer (“metastasise” if you want the technical word) which is what kills people. OncoSil device doesn’t do this.
    that’s probably why it’s used together with chemo.
    or maybe you think this is just more BS?
    OSL Price at posting: 14.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS Renascor produces graphite concentrate at Siviour, right on time to meet ex-China demand
right-arrow Created with Sketch.
NEWS What is going on here? Watch out for DroneShield, Pure Hydrogen, and Nel ASA
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.16 		Change
0.000(0.00%) 		Mkt cap ! $21.74M
Open High Low Value Volume
$1.16 $1.16 $1.16 $630 544

Buyers (Bids)

No. Vol. Price($)
1 1978 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 7380 1
View Market Depth
Last trade - 10.31am 28/07/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.